How do you work in the marketing department of Bayer HealthCare?

Bayer is a well-known company, and the treatment should be good.

Bayer Group is one of the world's leading Fortune 500 companies, and is at the forefront of the industry in many fields such as material innovation, crop science and health care.

China is Bayer's second largest market in Asia, and Bayer is confident in the future development potential of the Chinese market. In November 2001, the Bayer Group began to make a large-scale and epoch-making investment in the Shanghai Chemical Industry Park to build an integrated chemical base. At the same time, sales of its Materials Innovation Group's high-performance products in China also increased significantly.

In the future, Bayer will continue to benefit mankind with its high-quality products and services, and make life full of vitality with innovative technology. With the rapid growth of Bayer's business in China and the Asia-Pacific region, we will continue to create new high-quality jobs. We sincerely invite people with lofty ideals to join our team, and the company will provide perfect on-the-job training, excellent working environment and generous salary and benefits.

Germany's Fortune 500 companies, European-style enterprises are generally more humane than American-style enterprises. The treatment is a high-voltage line, so naturally you can't talk nonsense, but the benefits are super good, and it is definitely a fight with the domestic state-owned monopolies. What shuttles, free canteens, subsidies, commercial insurance are all available.

The company has more than 10,000 kinds of products? Who told you that? Don't talk nonsense if you don't know.

Bayer is divided into three modules: Bayer Pharma, Bayer Materials & Chemicals, and Bayer CropScience, which are focusing on the fields of medicine, chemical industry, construction, and agriculture.

It depends on which field you are asking, and I am familiar with medicine.

Are you talking about Bayer in Germany? He is a well-known enterprise in the world's top 500, the company's product range is more than 10,000, is the largest industrial group in Germany, very powerful.

Bayer HealthCare is a global provider of animal health, consumer health, and diabetes care.

There are 5 departments: Specialized Diagnostic System and Prescription Drugs. In 2005, Bayer HealthCare generated global sales of 9.4 billion euros.

In 2005, Bayer acquired Roche's OTC drug division, and Bayer has become one of the world's top three OTC drugs. Bayer Pharma's Pharmaceuticals Division continues to focus on common drug areas such as cardiovascular diseases, diabetes, infections and urology, and accelerates the development of specialty drugs, such as oncology drugs.

In China. Bayer HealthCare's relationship with China dates back to the early 20th century, when Bayer established its first production company in China in 1936, Bayer Pharma, which produced products including the world-famous painkiller aspirin.

Bayer HealthCare's rapid development in the Chinese market began in the 90s of the 20th century. In 1995, a modern pharmaceutical production plant was established in Beijing, and in 1997, the pharmaceutical production line was put into operation.

Currently, Bayer HealthCare has two joint ventures in China, Bayer HealthCare and Bayer (Sichuan) Animal Healthcare, which focus on four business areas: prescription drugs, consumer health products, medical diagnostics and animal health.

In 1936, Bayer established its first production company in China, Bayer Pharma, to produce a range of products, including the world-famous aspirin painkiller.

1992 Bayer returns to the Chinese market.

1995 Bayer established Bayer HealthCare and a factory in China.

In 1996, Bayer held the groundbreaking ceremony of the new pharmaceutical and health care plant.

In 1999, Bayer HealthCare **** plant passed the GMP certification certificate of the Certification Administration Center of the State Medical Products Administration of China.

In 2002, the National Medical Products Administration (NMPA) officially approved the indication of IGT (Hypoglycosis Intolerance), making China the first country in the world to approve the use of drugs to intervene in IGT, occupying a leading position in the field of diabetes clinical research.

In 2005, Bayer HealthCare acquired Roche Mass Pharmaceuticals.

In 2008, Bayer HealthCare acquired the assets and part of the business of Dongsheng Technology and Qidong Gaitianli Pharmaceutical Co., Ltd.